CDC, states update number of cases of lung injury associated with use of e-cigarette, or vaping, products

Media Statement

For Immediate Release: Thursday, October 10, 2019
Contact: Media Relations
(404) 639-3286

CDC, states update number of cases of lung injury associated with use of e-cigarette, or vaping, products

CDC today announced the updated number of confirmed and probable lung injury cases and deaths associated with the use of e-cigarette, or vaping, products.

Patients with Lung Injury

  • As of October 8, 2019, 1,299 confirmed and probable lung injury cases associated with use of e-cigarette, or vaping, products were reported by 49 states, the District of Columbia, and the U.S. Virgin Islands.
  • Among 573 patients with information on substances used in e-cigarette, or vaping, products in the 90 days prior to symptom onset:
    • 76% reported using THC-containing products, with or without nicotine-containing products;
    • 32% reported exclusive use of THC-containing products;
    • 58% reported using nicotine-containing products, with or without THC-containing products; and
    • 13% reported exclusive use of nicotine-containing products.
  • Among 1,043 patients with data on age and sex:
    • 70% of patients are male.
    • 80% of patients are under 35 years old.
      • 15% are under 18 years old
      • 21% are 18 to 20 years old.
      • 18% are 21 to 24 years old.
      • 26% are 25 to 34 years old.
      • 20% are 35 years or older.

Deaths

  • 26 deaths have been confirmed in 21 states: Alabama, California (3), Connecticut, Delaware, Florida, Georgia (2), Illinois, Indiana, Kansas (2), Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Jersey, New York, Oregon (2), Pennsylvania, Texas, and Virginia.
    • The median age of patients who have died is 49 years, ranging from 17 to 75 years old.

For updates on this investigation, visit: https://www.cdc.gov/lunginjury.

For information about the collection of e-cigarette products for possible testing by FDA, contact: FDAVapingSampleInquiries@fda.hhs.gov.

For information about collection and submission of clinical specimens for possible testing by CDC, see CDC’s Healthcare Provider web page.

Clinicians and health officials who have questions about this outbreak can contact: LungDiseaseOutbreak@cdc.gov.

All others, including the general public, who have questions about this outbreak can contact CDC-INFO at 800-232-4636, or visit https://wwwn.cdc.gov/dcs/ContactUs/Form.

###
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICESexternal icon

CDC works 24/7 protecting America’s health, safety and security. Whether disease start at home or abroad, are curable or preventable, chronic or acute, or from human activity or deliberate attack, CDC responds to America’s most pressing health threats. CDC is headquartered in Atlanta and has experts located throughout the United States and the world.

Page last reviewed: October 10, 2019